Novel Anticonvulsants: An Update on Efficacy

In this article, we’ll review the clinical data on three of the most frequently used of the novel anticonvulsants: Trileptal (oxcarbazepine), Topamax (topiramate), and Neurontin (gabapentin). We cover Lamictal in this month’s expert interview with Nassir Ghaemi.

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.